Notably, we proved that CAR.CD123-NK cells significantly eradicated CD123+ cells in all CD38+CD34−, CD38+CD34+, and CD38−CD34+ cell subsets compared to the control conditions (leukaemia alone and NT-NK cells; Fig. 4C–F). Here, CD38 is linked to leukemia.